Acolbifene hydrochloride is a pure antiestrogen and selective estrogen receptor (ER) antagonist with potent anticancer activity; it inhibits estradiol-stimulated proliferation of human breast cancer cells (ZR-75-1, MCF-7, T-47D) without intrinsic estrogenic activity; it reduces food intake, body weight gain (primarily fat mass), and cholesterolemia in rats; it prevents tumor growth in vivo.